US 10004691
Orally disintegrable tablet
granted A61KA61K31/4439A61K31/616
Quick answer
US patent 10004691 (Orally disintegrable tablet) held by Takeda Pharmaceutical Company Limited expires Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jun 26 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/4439, A61K31/616, A61K9/0056, A61K9/2018